Entia Biosciences Stock Fundamentals
| ERGO Stock | USD 0.0002 0.00 0.00% |
Entia Biosciences fundamentals help investors to digest information that contributes to Entia Biosciences' financial success or failures. It also enables traders to predict the movement of Entia Pink Sheet. The fundamental analysis module provides a way to measure Entia Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Entia Biosciences pink sheet.
Entia |
Entia Biosciences Company Shares Outstanding Analysis
Entia Biosciences' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Entia Biosciences Shares Outstanding | 33.66 M |
Most of Entia Biosciences' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Entia Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Entia Biosciences has 33.66 M of shares currently outstending. This is 81.35% lower than that of the Healthcare sector and 68.5% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 94.11% higher than that of the company.
Entia Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Entia Biosciences's current stock value. Our valuation model uses many indicators to compare Entia Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Entia Biosciences competition to find correlations between indicators driving Entia Biosciences's intrinsic value. More Info.Entia Biosciences is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Entia Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Entia Biosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Entia Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Entia Biosciences' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Entia Biosciences could also be used in its relative valuation, which is a method of valuing Entia Biosciences by comparing valuation metrics of similar companies.Entia Biosciences is currently under evaluation in shares outstanding category among its peers.
Entia Fundamentals
| Return On Asset | -1.64 | |||
| Operating Margin | (4.40) % | |||
| Current Valuation | 235.63 K | |||
| Shares Outstanding | 33.66 M | |||
| Price To Earning | (0.50) X | |||
| Price To Sales | 0.89 X | |||
| Revenue | 265.47 K | |||
| Gross Profit | 173.97 K | |||
| EBITDA | (1.29 M) | |||
| Net Income | (1.4 M) | |||
| Cash And Equivalents | 76.05 K | |||
| Debt To Equity | (1.57) % | |||
| Current Ratio | 0.11 X | |||
| Book Value Per Share | (0.07) X | |||
| Cash Flow From Operations | (715.1 K) | |||
| Earnings Per Share | (0.05) X | |||
| Beta | 12.64 | |||
| Market Capitalization | 235.63 K | |||
| Total Asset | 439.14 K | |||
| Retained Earnings | (13.37 M) | |||
| Working Capital | (1.64 M) | |||
| Current Asset | 73 K | |||
| Current Liabilities | 1.71 M | |||
| Z Score | -52.2 | |||
| Net Asset | 439.14 K |
About Entia Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Entia Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Entia Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Entia Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon. Total Nutraceutical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 6 people.
Pair Trading with Entia Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Entia Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entia Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Entia Pink Sheet
| 0.8 | NVO | Novo Nordisk AS Sell-off Trend | PairCorr |
| 0.8 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.79 | NONOF | Novo Nordisk AS | PairCorr |
| 0.74 | QSAM | Qsam Biosciences | PairCorr |
| 0.63 | CSLLY | CSL | PairCorr |
The ability to find closely correlated positions to Entia Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Entia Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Entia Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Entia Biosciences to buy it.
The correlation of Entia Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Entia Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Entia Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Entia Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Entia Pink Sheet
Entia Biosciences financial ratios help investors to determine whether Entia Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entia with respect to the benefits of owning Entia Biosciences security.